A new brake on cellular energy production discoveredJuly 27, 2007A condition that has to be met for the body to be able to keep warm, move and even survive is that the mitochondria - the cells' power stations - release the right amounts of energy. Scientists at Karolinska Institutet have now identified the first known factor that acts as a brake on cellular energy production. Mitochondria release energy through a process known as cellular respiration - a chemical process inside each mitochondrion that results in the production of the cell's energy currency, the molecule ATP. As important parts of the respiratory chain are encoded by mitochrondrial DNA, mtDNA, the cell can adapt its energy production to varying needs by increasing or reducing the expression of mtDNA. However, very little is known about how this process is regulated.
Two research teams at Karolinska Institutet, led by Claes Gustafsson and Nils-Göran Larsson respectively, have now made an important breakthrough by discovering an entirely new mitochondrial factor, MTERF3. This new factor inhibits the expression of mtDNA and can thus slow down the cell's energy production. The discovery, which is published in the journal Cell, may in future lead to completely new ways of treating various diseases. Impaired mitochondrial function gives rise to a cellular energy crisis and probably plays an important role in a number of common diseases such as diabetes, heart failure and Parkinson's disease, as well as in normal ageing. Karolinska Institutet | |||||||||||||||||||||
|
Related Cellular Energy Current Events and Cellular Energy News Articles Tuberculosis drug shows promise against latent bacteria A new study has shown that an investigational drug (R207910, currently in clinical trials against multi-drug resistant tuberculosis strains) is quite effective at killing latent bacteria. This revelation suggests that R207910 may lead to improved and shortened treatments for this globally prevalent disease. A single mechanism for hypertension, insulin resistance and immune suppression Many of the 75 million Americans with essential hypertension also develop diabetes and other complications in addition to their high blood pressure, and researchers have discovered a common molecular mechanism in a strain of rat that explains why such metabolic disorders arise together in mammals. Metformin increases pathologic complete response rates in breast cancer patients with diabetes Metformin, the common first-line drug for type 2 diabetes, may be effective in increasing pathologic complete response rates in diabetic women with early stage breast cancer who took the drug during chemotherapy prior to having surgery, paving the way for further research of the drug as a potential cancer therapy, according to researchers at The University of Texas M. D. Anderson Cancer Center. Mayo researchers look for explanation behind high incidence of diabetes among Asian Indians The incidence of type 2 diabetes is rising, especially in urbanized parts of the world where sedentary lifestyles and obesity abound. In addition to weight and inactivity, race puts some people at increased risk for developing type 2 diabetes. Rising ocean temperatures, pollution have oysters in hot water Oysters exposed to high water temperatures and a common heavy metal are unable to obtain sufficient oxygen and convert it to cellular energy. BGSU biologist trying to crack microscopic code The Bowling Green State University biologist wants to crack the communication code of proteins, especially the ones whose "talking" aids and abets disease. Researchers develop flood-tolerant California rice Rice grown anywhere in the world soon could be made completely flood-tolerant because of new research by UC Riverside geneticists, done in collaboration with scientists at UC Davis and the International Rice Research Institute in the Philippines. Study identifies potential drug target for Huntington's disease An enzyme known to be critical for the repair of damaged cells and the maintenance of cellular energy may be a useful target for new strategies to treat Huntington's disease (HD) and other disorders characterized by low cellular energy levels. Genetics behind developmental brain disorders may play a wider role with congenital diseases Findings of a recent genetic study on developmental brain disorders may be the "tip of an iceberg" revealing factors involved with a number of congenital diseases, according to UC Irvine researchers. New understanding of parasite cell structures may provide treatments for serious tropical diseases Don't even think about trying to pronounce it. Although it is found in many organisms including humans, glycosylphosphatidylinositol has remained a mouthful for laymen and a puzzle for scientists. More Cellular Energy Current Events and Cellular Energy News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||